Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Joseph Michael Fitzgerald

At a glance: Joseph Michael Fitzgerald is Evp & Group Pres, Cardiology at Boston Scientific (BSX). Their latest SEC Form 4, filed Nov 4, 2025, reported a sale of $363K. On file: 0 purchase lines ($0) and 5 sale lines ($9.9M).

Disclosed holdings: about $7.6M of BSX stock: 178,342 shares reported on their latest Form 4 (filed Nov 4, 2025), valued at the Nov 20, 2026 close of $42.72. This counts only BSX shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.

Evp & Group Pres, Cardiology at Boston Scientific Corp (BSX)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $9.9M

Joseph Michael Fitzgerald's InsiderPrint

5 trades from SEC Form 4 filings, 2025 to 2025, drawn as one fingerprint.

InsiderPrint of Joseph Michael Fitzgerald: 5 trades, 2025 to 20252025: 0 buys, 5 sales

Reading this print: Almost only sells, trading about 5 times a year, typically $1.7M a trade; most sales are on a pre-planned 10b5-1 schedule.

  • Bump outward: a purchase (0)
  • Dent inward: a sale (5)
  • One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.

Insiders with a similar print

  1. Michael G. BarrettCEO · MGNI · 100% match
  2. Donald E. SimmonsPresident · TT · 100% match
  3. Carl DambkowskiDirector · ORKA · 100% match
  4. Timothy L. ChambersSr Vp & Pres - Tools · SNA · 100% match
  5. Adam M. VenessGeneral Counsel · DNTH · 100% match

Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.

Reported trades

Filed Stock Type Shares Price Value Since
Nov 4SEC BSXBoston Scientific Corp Sell Plan 3,600224,742 held (−2%) $100.75 $363K -57.6%
Nov 4SEC BSXBoston Scientific Corp Sell Plan 16,928207,814 held (−8%) $99.76 $1.7M -57.2%
Nov 4SEC BSXBoston Scientific Corp Sell Plan 29,472178,342 held (−14%) $99.14 $2.9M -56.9%
Oct 1SEC BSXBoston Scientific Corp Sell Plan 8,245220,097 held (−4%) $98.91 $816K -56.8%
Oct 1SEC BSXBoston Scientific Corp Sell Plan 41,755178,342 held (−19%) $98.38 $4.1M -56.6%
  • Sell

    Evp & Group Pres, Cardiology Joseph Michael Fitzgerald sold $363K of BSX at $100.75 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Evp & Group Pres, Cardiology Joseph Michael Fitzgerald sold $1.7M of BSX at $99.76 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Evp & Group Pres, Cardiology Joseph Michael Fitzgerald sold $2.9M of BSX at $99.14 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Evp & Group Pres, Cardiology Joseph Michael Fitzgerald sold $816K of BSX at $98.91 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Evp & Group Pres, Cardiology Joseph Michael Fitzgerald sold $4.1M of BSX at $98.38 — pre-scheduled 10b5-1 plan sale.

Follow Joseph Michael Fitzgerald

Get one email when Joseph Michael Fitzgerald files a new purchase or sale. Free.

At most one email a day about Joseph Michael Fitzgerald, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.